E-LIB Suche - Ergebnisse für: Alm, R.

1

Analysis of Staphylococcus aureus clinical isolates with re..:

Alm, R. A. ; McLaughlin, R. E. ; Kos, V. N....
Journal of Antimicrobial Chemotherapy. 69 (2014) 8 - p. 2065-2075 , 2014

Link: https://doi.org/10.1093/..

2

IL-25 expands innate lymphoid cells type 2 and inhibits ath..:

Fredrikson, G. Nordin ; Mantani, P.T. ; Dunér, P....
Atherosclerosis. 235 (2014) 2 - p. e150 , 2014

Link: https://doi.org/10.1016/..

3

Low levels of igm antibodies against an age-modified apolip..:

Engelbertsen, D. ; Minguez, J. Vallejo ; Fredrikson, G. Nordin...
Atherosclerosis. 235 (2014) 2 - p. e44-e45 , 2014

Link: https://doi.org/10.1016/..

4

Activity of avibactam against Enterobacter cloacae producin..:

Lahiri, S. D. ; Giacobbe, R. A. ; Johnstone, M. R..
Journal of Antimicrobial Chemotherapy. 69 (2014) 11 - p. 2942-2946 , 2014

Link: https://doi.org/10.1093/..

5

Plasma levels of igg anti oxidized ldl predict the occurren..:

Asciutto, G. ; Dias, N. ; Fredrikson, G....
Atherosclerosis. 235 (2014) 2 - p. e85 , 2014

Link: https://doi.org/10.1016/..

6

Development of EUCAST zone diameter breakpoints and quality..:

Koeth, L. M. ; Matuschek, E. ; Kahlmeter, G...
European Journal of Clinical Microbiology & Infectious Diseases. 33 (2014) 9 - p. 1511-1517 , 2014

Link: https://doi.org/10.1007/..

7

379 THE AKITA-LDLR-/- MOUSE AS A MODEL OF DIABETIC ATHEROSC..:

Engelbertsen, D. ; To, F. ; Dunér, P....
Atherosclerosis Supplements. 12 (2011) 1 - p. 81 , 2011

Link: https://doi.org/10.1016/..

8

Patients with irritable bowel syndrome and dysmotility expr..:

Ohlsson, B. ; Sjöberg, K. ; Alm, R..
Neurogastroenterology & Motility. 23 (2011) 11 - p. 1000-e459 , 2011

Link: https://doi.org/10.1111/..

9

Associations between autoantibodies against apolipoprotein ..:

Fredrikson, G. N. ; Anand, D. V. ; Hopkins, D....
Diabetologia. 52 (2009) 7 - p. 1426-1433 , 2009

Link: https://doi.org/10.1007/..

10

Immune responses against fibronectin modified by lipoprotei..:

Dunér, P. ; To, F. ; Alm, R....
Journal of Internal Medicine. 265 (2009) 5 - p. 593-603 , 2009

Link: https://doi.org/10.1111/..

11

IMMUNE RESPONSES AGAINST FIBRONECTIN MODIFIED BY REACTIVE A..:

Dunér, P. ; Bengtsson, E. ; To, F....
Atherosclerosis Supplements. 9 (2008) 1 - p. 57-58 , 2008

Link: https://doi.org/10.1016/..

12

Th-P15:128 Immune responses against aldehyde-modified fibro..:

Dunér, P. ; Bengtsson, E. ; To, F....
Atherosclerosis Supplements. 7 (2006) 3 - p. 521 , 2006

Link: https://doi.org/10.1016/..

13

We-W41:3 Increased levels of IGG1 against an aldehyde-modif..:

Fredrikson, G.N. ; Schiopu, A. ; Berglund, G....
Atherosclerosis Supplements. 7 (2006) 3 - p. 327 , 2006

Link: https://doi.org/10.1016/..

14

PROTEIOS: an open source proteomics initiative:

Garden, P. ; Alm, R. ; Hakkinen, J.
Bioinformatics. 21 (2005) 9 - p. 2085-2087 , 2005

Link: https://doi.org/10.1093/..

15

W12-P-016 Association between IGM against an aldehyde-modif..:

Fredrikson, G.N. ; Hedblad, B. ; Berglund, G....
Atherosclerosis Supplements. 6 (2005) 1 - p. 65 , 2005

Link: https://doi.org/10.1016/..